Netscientific Share Discussion Threads

[loafofbread] 01/2/2024 23:42

January Portfolio & Investment News

After a dynamic start to 2024, we are excited to share the January highlights from the EMV Capital and NetScientific PLC group deep tech portfolio:

▶ Glycotest, Inc., the US based liver diagnostics company, has closed a $1m follow-on investment from Fosun 复星 to support the development and validation of its assays ahead of commercial launch.
▶ Wanda Health, the intelligent platform for Remote Patient Monitoring and Virtual Care, has achieved ISO 13485:2016 certification for its Medical Device Quality Management System.
▶ Q-Bot Ltd, the developer of robots for use in the construction and retrofit industry, has been featured in the UK Green Building Council (UKGBC) Trends in Sustainable Solutions in the Built Environment Report 2023.
▶ DeepTech Recycling, the plastic recycling technology business, is progressing its commercial operations with new strategic hires and a transition into new facilities following its £1m first close in December.
▶ Ventive Limited, the heat pump and passive air ventilation specialist, is scaling up its team with two senior hires following a successful first closing of its investment programme in 2023.
▶ ProAxsis, the respiratory diagnostics company, has strengthened its Board with the appointment of Steve Myint, an internationally experienced clinician with board level experience in biotech and pharmaceuticals, as a Non-Executive Director. This follows the appointment of Alan Markey as a Chairman in 2023.
▶ PointGrab, a smart sensing solution for commercial real estate technology industries, has recently welcomed Amir EINAV, an experienced business leader with a strong GTM background, as its CEO, and David Gelber as its Chairman.
▶ Martlet Capital has participated in £3.5m funding round for OctaiPipe, the end-to-end Edge AI platform, and £5.5m funding round for Xampla, a cleantech company advancing plant-based, biodegradable material that aims to replace plastic.
▶ SageTech Medical attended the Association of Anaesthetists Winter Scientific Meeting, showcasing its solutions at the Dräger stand.

👇 Subscribe to our newsletter for more insights and updates: hxxps://lnkd.in/etxzjW6J

[blakieboy7] 30/1/2024 11:46

NSCI starting to wake up

[blakieboy7] 30/1/2024 08:02

You're right Loaf! PDSB closed at 6 dollars after hours

[loafofbread] 29/1/2024 21:40

Staggering lack of interest in NSCI.

PDSB back up to half our M Cap.

Looking forward to PDSB partnership news and P111 start which will probably double it's share price

60p is a gift!

[blakieboy7] 29/1/2024 20:45

Pdsb up 8% now

[blakieboy7] 29/1/2024 13:58

PDSB up over 3% pre market

[loafofbread] 28/1/2024 13:37

Fridays gain adds another £400K to the pot.

Just saying.

[blakieboy7] 28/1/2024 09:20

https://x.com/pharmdca/status/1751348500049346669?s=46

[blakieboy7] 28/1/2024 09:07

Interesting Twitter post on PDSB and it's potential https://stkt.co/TXbup9Gc

[longterm3] 26/1/2024 15:52

Thought I would add while it is still quiet.

[blakieboy7] 26/1/2024 14:41

PDSB up 4% already

[blakieboy7] 26/1/2024 10:44

An Investor Chronicles article would be warmly received!!

[loafofbread] 26/1/2024 09:55

Panmure Gordon were appointed to raise our profile and attract new investors.

Assumed they would put out a decent note but still waiting.

[loafofbread] 26/1/2024 09:50

As they all ready own almost 50% it must be an option.

A small cap listing is not what it used to be!

They know what's coming down the road and it's worth a lot more than 60p.

We have always been under the radar but current interest is a new time low when the story is the best it has ever been.

[kingston78] 26/1/2024 09:45

Many stocks are undervalued until a cash bid comes along propelling the share price by 100%. It has happened many times before and it will happen again. Hopefully, patience will be rewarded.

[blakieboy7] 26/1/2024 01:40

7.5% rather!

[blakieboy7] 26/1/2024 01:39

Also PDSB closed up 6.5% yesterday

[blakieboy7] 26/1/2024 01:39

We need a Simon Thomson (I think that was his name) boost!!

[loafofbread] 26/1/2024 00:12

So our holding in PDSB has gone up by £2M since it's low a few weeks back and we have had confirmation that our £10M Glycotest investment is still going strong.

The proceeds of the Investment will, inter alia, support Glycotest in the development and validation of its assays ahead of commercial launch. Such validation is possible after the completion in 2023 of subject enrolment and sample collection in Glycotest's clinical validation study, providing a valuable biobank which the company believes now represents one of the world's largest collections of liver cancer blood samples. Glycotest is in advanced negotiations with a number of prospective collaboration partners, further details of which shall be reported in due course.

In response our share price has gone up by 1p.

You couldn't make it up!

[blakieboy7] 24/1/2024 08:46

I'm particularly excited about PDSB

[loafofbread] 23/1/2024 22:18

NSCI should be red hot.

Glycotest valuation pretty much confirmed by todays funding news and PDSB signs up a CMO who in his last job signed a $5B deal with Keytruda.

He obviously thinks his 200k share at $4.40 are going to be worth a lot more some time soon!

Buy or top up before the herd arrives because this type of mis price just won't last.

[blakieboy7] 23/1/2024 21:42

PDSB closed 12% up

[blakieboy7] 23/1/2024 16:50

PDSB up over 7% today. They've just appointed a new CMO